For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Publications

Found 147 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is R  [Clear All Filters]
2020
Gaudino M, Benedetto U, Fremes S, Ballman K, Biondi-Zoccai G, Sedrakyan A, Nasso G, Raman J, Buxton B, Hayward PA et al..  2020.  Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.. JAMA. 324(2):179-187.
Gaudino M, Benedetto U, Fremes S, Ballman K, Biondi-Zoccai G, Sedrakyan A, Nasso G, Raman J, Buxton B, Hayward PA et al..  2020.  Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.. JAMA. 324(2):179-187.
Ramkumar N, Suckow BD, Arya S, Sedrakyan A, Mackenzie TA, Goodney PP, Brown JR.  2020.  Association of Sex With Repair Type and Long-term Mortality in Adults With Abdominal Aortic Aneurysm.. JAMA Netw Open. 3(2):e1921240.
Carey RM, Fathy R, Shah RR, Rajasekaran K, Cannady SB, Newman JG, Ibrahim SA, Brant JA.  2020.  Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.. JAMA Netw Open. 3(1):e1919697.
Zhang WZ, Rice MC, Hoffman KL, Oromendia C, Barjaktarevic IZ, J Wells M, Hastie AT, Labaki WW, Cooper CB, Comellas AP et al..  2020.  Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.. JCI Insight. 5(3)
Dhruva SS, Parzynski CS, Gamble GM, Curtis JP, Desai NR, Yeh RW, Masoudi FA, Kuntz R, Shaw RE, Marinac-Dabic D et al..  2020.  Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.. J Am Heart Assoc. 9(4):e013606.
Pandya A, Soeteman DI, Gupta A, Kamel H, Mushlin AI, Rosenthal MB.  2020.  Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework? Circ Cardiovasc Qual Outcomes. 13(7):e006492.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB et al..  2020.  Clinical Characteristics of Covid-19 in New York City.. N Engl J Med.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB et al..  2020.  Clinical Characteristics of Covid-19 in New York City.. N Engl J Med.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB et al..  2020.  Clinical Characteristics of Covid-19 in New York City.. N Engl J Med.
Magbanua MJesus M, Savenkov O, Asmus EJ, Ballman K, Scott JH, Park JW, Dickler M, Partridge AH, Carey LA, Winer E et al..  2020.  Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab.. Clin Cancer Res.
Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al..  2020.  CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.
Alexopoulos GS, Raue PJ, Banerjee S, Marino P, Renn BN, Solomonov N, Adeagbo A, Sirey JAnne, Hull TD, Kiosses DN et al..  2020.  Comparing the streamlined psychotherapy "Engage" with problem-solving therapy in late-life major depression. A randomized clinical trial.. Mol Psychiatry.
Alexopoulos GS, Raue PJ, Banerjee S, Marino P, Renn BN, Solomonov N, Adeagbo A, Sirey JAnne, Hull TD, Kiosses DN et al..  2020.  Comparing the streamlined psychotherapy "Engage" with problem-solving therapy in late-life major depression. A randomized clinical trial.. Mol Psychiatry.
Ahmad FS, Ricket IM, Hammill BG, Eskenazi L, Robertson HR, Curtis LH, Dobi CD, Girotra S, Haynes K, Kizer JR et al..  2020.  Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.. Circ Cardiovasc Qual Outcomes. 13(6):e006292.
Ahmad FS, Ricket IM, Hammill BG, Eskenazi L, Robertson HR, Curtis LH, Dobi CD, Girotra S, Haynes K, Kizer JR et al..  2020.  Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.. Circ Cardiovasc Qual Outcomes. 13(6):e006292.
Ahmad FS, Ricket IM, Hammill BG, Eskenazi L, Robertson HR, Curtis LH, Dobi CD, Girotra S, Haynes K, Kizer JR et al..  2020.  Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.. Circ Cardiovasc Qual Outcomes. 13(6):e006292.
Ahmad FS, Ricket IM, Hammill BG, Eskenazi L, Robertson HR, Curtis LH, Dobi CD, Girotra S, Haynes K, Kizer JR et al..  2020.  Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.. Circ Cardiovasc Qual Outcomes. 13(6):e006292.
RoyChoudhury A, Xu C.  2020.  A dataset on body composition, strength and performance in older adults.. Data Brief. 29:105103.
Kaur S, Silver G, Samuels S, Rosen AH, Weiss M, Mauer EA, Gerber LM, Greenwald BM, Traube C.  2020.  Delirium and Developmental Disability: Improving Specificity of a Pediatric Delirium Screen.. Pediatr Crit Care Med. 21(5):409-414.
Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM.  2020.  Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.. J Subst Abuse Treat. 112S:18-27.
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..  2020.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Ghomrawi HMK, Mushlin AI, Kang R, Banerjee S, Singh JA, Sharma L, Flink C, Nevitt M, Neogi T, Riddle DL.  2020.  Examining Timeliness of Total Knee Replacement Among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal Cohorts.. J Bone Joint Surg Am. 102(6):468-476.